Zobrazeno 1 - 10
of 327
pro vyhledávání: '"de Valk, V"'
Introduction: There are growing concerns among European health authorities regarding increasing prices for new cancer medicines, prices not necessarily linked to health gain and the implications for the sustainability of their healthcare systems. Are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::78ee30411f7b7ee04e0cea9458acf3bd
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3103202
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3103202
Autor:
Godman B; Division of Clinical Pharmacology, Karolinska Institute, Karolinska University Hospital Huddinge, Stockholm, Sweden.; Division of Pharmacoepidemiology, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK.; Division of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa.; School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia., Hill A; Institute of Translational Medicine, University of Liverpool, UK., Simoens S; Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Belgium., Selke G; Wissenschaftliches Institut Der AOK (WIdO), Berlin, Germany., Selke Krulichová I; Department of Medical Biophysics, Faculty of Medicine in Hradec Králové, Charles University, Hradec, Králové, Czech Republic., Zampirolli Dias C; Faculty of Pharmacy, Postgraduate Program in Medicines and Pharmaceutical Services, Federal University of Minas Gerais (UFMG), Belo Horizonte, Minas Gerais, Brazil.; SUS Collaborating Centre for Technology Assessment and Excellence in Health (CCATES), Belo Horizonte, Minas Gerais, Brazil., Martin AP; Faculty of Health and Life Sciences, Liverpool, UK.; QC Medica, Sim Balk Lane, York UK., Oortwijn W; Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands., Timoney A; Division of Pharmacoepidemiology, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK.; NHS Lothian, Edinburgh, UK., Gustafsson LL; Division of Clinical Pharmacology, Karolinska Institute, Karolinska University Hospital Huddinge, Stockholm, Sweden., Voncina L; Faculty of Health Studies, Rijeka, Croatia., Kwon HY; Division of Pharmacoepidemiology, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK.; Division of Biology & Public Health, Mokwon University, Daejeon, Korea., Gulbinovic J; Department of Pathology, Forensic Medicine and Pharmacology, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius University, Vilnius, Lithuania., Gotham D; Independent Researcher, Boston, MA, United States., Wale J; Independent Consumer Advocate, Brunswick, Victoria, Australia., Cristina Da Silva W; Faculty of Pharmacy, Postgraduate Program in Medicines and Pharmaceutical Services, Federal University of Minas Gerais (UFMG), Belo Horizonte, Minas Gerais, Brazil.; Data and Knowledge Integration Center for Health(CIDACS), Fundação Oswaldo Cruz (FIOCRUZ)/ Salvador, Bahia, Brazil., Bochenek T; Department of Nutrition and Drug Research, Faculty of Health Sciences, Jagiellonian University Medical College, Krakow, Poland., Allocati E; Istituto Di Ricerche Farmacologiche 'Mario Negri' IRCCS, Milan, Italy., Kurdi A; Division of Pharmacoepidemiology, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK.; Division of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa.; Department of Pharmacology, College of Pharmacy, Hawler Medical University, Erbil, Iraq., Ogunleye OO; Department of Pharmacology, Therapeutics and Toxicology, Lagos State University College of Medicine, Ikeja, Lagos, Nigeria.; Department of Medicine, Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria., Meyer JC; Division of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa., Hoxha I; Department of Pharmacy, Faculty of Medicine, University of Medicine, Tirana, Albania., Malaj A; University of Medicine, Tirana, Albania., Hierländer C; Department of Pharmaceutical Affairs, Federation of Social Insurances, Vienna, Austria., Sauermann R; Department of Pharmaceutical Affairs, Federation of Social Insurances, Vienna, Austria., Hamelinck W; Statistics Department, Bruxelles, Belgium., Petrova G; Faculty of Pharmacy, Department of Social Pharmacy and Pharmacoeconomics, Medical University of Sofia, Sofia, Bulgaria., Laius O; State Agency of Medicines, Tartu, Estonia., Langner I; Wissenschaftliches Institut Der AOK (WIdO), Berlin, Germany., Yfantopoulos J; School of National and Kapodistrian University of Athens Athens Greece., Joppi R; Pharmaceutical Drug Department, Azienda Sanitaria Locale of Verona, Verona, Italy., Jakupi A; Faculty of Pharmacy, UBT - Higher Education Institution, Prishtina, Kosovo., Greiciute-Kuprijanov I; Department of Pharmacy, Ministry of Health of the Republic of Lithuania, Vilnius, Lithuania., Vella Bonanno P; Division of Pharmacoepidemiology, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK., Piepenbrink JH; National Health Care Institute (ZIN), XH, Diemen, Netherlands., de Valk V; National Health Care Institute (ZIN), XH, Diemen, Netherlands., Wladysiuk M; HTA Consulting, Cracow, Poland., Marković-Peković V; Faculty of Medicine, Department of Social Pharmacy, University of Banja Luka, Banja Luka, Republic of Srpska, Bosnia and Herzegovina., Mardare I; Faculty of Medicine, Public Health and Management Department, 'Carol Davila' University of Medicine and Pharmacy Bucharest, Bucharest, Romania., Fürst J; Health Insurance Institute, Ljubljana, Slovenia., Tomek D; Faculty of Medicine, Slovak Medical University in Bratislava, Bratislava, Slovakia., Obach Cortadellas M; Drug Department, Catalan Health Service, Catalan Health Service, Barcelona, Spain., Zara C; Drug Department, Catalan Health Service, Catalan Health Service, Barcelona, Spain., Pontes C; Drug Department, Catalan Health Service, Catalan Health Service, Barcelona, Spain.; Department of Pharmacology, Therapeutics and Toxicology, Universitat Autònoma De Barcelona, Barcelona, Spain., McTaggart S; Public Health Scotland, Edinburgh, UK., Laba TL; Centre for Health Economics Research and Evaluation, University of Technology Sydney, Broadway, Sydney, NSW., Melien Ø; Reviews and Health Technology Assessments, Norwegian Institute of Public Health, Oslo, Norway., Wong-Rieger D; Health Data Science, Institute of Population Health, Liverpool, Canadian Organization for Rare Disorders, Toronto, Ontario, Canada., Bae S; College of Pharmacy, Ewha Woman's University, Seoul, South Korea., Hill R; Health Data Science, Institute of Population Health Liverpool Reviews and Implementation Group, Whelan Building, University of Liverpool, Liverpool, UK.
Publikováno v:
Expert review of pharmacoeconomics & outcomes research [Expert Rev Pharmacoecon Outcomes Res] 2021 Aug; Vol. 21 (4), pp. 527-540. Date of Electronic Publication: 2021 Mar 11.
Autor:
Glerum PJ; Medicines Evaluation Board, P.O. Box 8275, 3503 GB, Utrecht, The Netherlands. pieter.glerum@maastrichtuniversity.nl.; Department of Clinical Pharmacy & Toxicology, Maastricht University Medical Centre+, Maastricht, The Netherlands. pieter.glerum@maastrichtuniversity.nl., Maliepaard M; Medicines Evaluation Board, P.O. Box 8275, 3503 GB, Utrecht, The Netherlands.; Department of Pharmacology and Toxicology, Radboud University Medical Centre, Nijmegen, The Netherlands., de Valk V; National Health Care Institute, Diemen, The Netherlands., Burger DM; Department of Pharmacy, Radboud University Medical Centre, Nijmegen, The Netherlands., Neef K; Department of Clinical Pharmacy & Toxicology, Maastricht University Medical Centre+, Maastricht, The Netherlands.
Publikováno v:
BMC health services research [BMC Health Serv Res] 2020 Jul 13; Vol. 20 (1), pp. 650. Date of Electronic Publication: 2020 Jul 13.
Autor:
Glerum PJ; Medicines Evaluation Board, Utrecht, The Netherlands.; Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Centre, Maastricht, The Netherlands., Maliepaard M; Medicines Evaluation Board, Utrecht, The Netherlands.; Department of Pharmacology and Toxicology, Radboud University Medical Centre, Nijmegen, The Netherlands., de Valk V; National Health Care Institute, Diemen, The Netherlands., Scholl JHG; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, The Netherlands., van Hunsel FPAM; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, The Netherlands., van Puijenbroek EP; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, The Netherlands.; Pharmaco-Therapy, Epidemiology, and Economics, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands., Burger DM; Department of Pharmacy, Radboud University Medical Centre, Nijmegen, The Netherlands., Neef K; Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Centre, Maastricht, The Netherlands.
Publikováno v:
Clinical and translational science [Clin Transl Sci] 2020 May; Vol. 13 (3), pp. 599-607. Date of Electronic Publication: 2020 Feb 12.
Autor:
Costa, M (Marco), Carere, RG, Lichtenstein, SV, Foley, DP, de Valk, V, Lindenboom, W, Roose, PCH, van Geldorp, TR, macaya, C, Castanon, JL, Fernandez-Avilèz, F, Herreros Gonzáles, J, Heyer, G, Unger, F, Serruys, PWJC (Patrick), ARTS Study Group,
Publikováno v:
Circulation, 104, 2689-2693. Lippincott Williams & Wilkins
Background Although it has been suggested that elevation of CK-MB after percutaneous coronary intervention is associated with adverse clinical outcomes, limited data are available in the setting of coronary bypass grafting. The aim of the present stu
Autor:
Glerum PJ; Medicines Evaluation Board, Utrecht, The Netherlands.; Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Centre+, Maastricht, The Netherlands., Yamada WM; Laboratory of Applied Pharmacokinetics and Bioinformatics, Children's Hospital Los Angeles, University of Southern California, Los Angeles, California, USA., Neely MN; Laboratory of Applied Pharmacokinetics and Bioinformatics, Children's Hospital Los Angeles, University of Southern California, Los Angeles, California, USA., Burger DM; Department of Pharmacy, Radboud University Medical Centre, Nijmegen, The Netherlands., Maliepaard M; Medicines Evaluation Board, Utrecht, The Netherlands.; Department of Pharmacology and Toxicology, Radboud University Medical Centre, Nijmegen, The Netherlands., Neef C; Department of Clinical Pharmacy and Toxicology, CARIM, Maastricht University, Maastricht, The Netherlands.
Publikováno v:
British journal of clinical pharmacology [Br J Clin Pharmacol] 2024 Jul; Vol. 90 (7), pp. 1576-1585. Date of Electronic Publication: 2023 Feb 02.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Katsuki, Masahito1,2 (AUTHOR) ktk1122nigt@gmail.com, Matsumori, Yasuhiko3 (AUTHOR), Ichihara, Taisuke4 (AUTHOR), Yamada, Yuya4 (AUTHOR), Kawamura, Shin5 (AUTHOR), Kashiwagi, Kenta6 (AUTHOR), Koh, Akihito5 (AUTHOR), Goto, Tetsuya1 (AUTHOR), Kaneko, Kazuma2,7 (AUTHOR), Wada, Naomichi1,2 (AUTHOR), Yamagishi, Fuminori8 (AUTHOR)
Publikováno v:
Life (2075-1729). Jan2024, Vol. 14 Issue 1, p96. 15p.
Autor:
Masahito Katsuki1,2 ktk1122nigt@gmail.com, Yasuhiko Matsumori3, Taisuke Ichihara4, Yuya Yamada4, Shin Kawamura5, Kenta Kashiwagi6, Akihito Koh5, Tetsuya Goto1, Kazuma Kaneko2,7, Naomichi Wada1,2, Fuminori Yamagishi8
Publikováno v:
Cephalalgia. Jan2024, Vol. 44 Issue 1, p1-16. 16p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.